04/12/2012 - Press release
Using computational techniques, researchers have shown how a protein responsible for the maturation of the virus releases itself to initiate infection
HIV proteasa cutting the poly-protein chain. Source: IMIM
Bioinformaticians at IMIM (Hospital del Mar Medical Research Institute) and UPF (Pompeu Fabra University) have used molecular simulation techniques to explain a specific step in the maturation of the HIV virions, i.e., how newly formed inert virus particles become infectious, which is essential in understanding how the virus replicates. These results, which have been published in the latest edition of PNAS, could be crucial to the design of future antiretrovirals.
HIV virions mature and become infectious as a result of the action of a protein called HIV protease. This protein acts like a pair of scissors, cutting the long chain of connected proteins that form HIV into individual proteins that will form the infectious structure of new virions. According to the researchers of the IMIM-UPF computational biophysics group, “One of the most intriguing aspects of the whole HIV maturation process is how free HIV protease, i.e. the ‘scissors protein,’ appears for the first time, since it is also initially part of the long poly-protein chains that make up new HIV virions."
Using ACEMD a software for molecular simulations and a technology known as GPUGRID.net, Gianni De Fabritiis’ group has demonstrated that the first “scissors proteins” can cut themselves out from within the middle of these poly-protein chains. They do this by binding one of their connected ends (the N-terminus) to their own active site and then cutting the chemical bond that connects them to the rest of the chain. This is the initial step of the whole HIV maturation process. If the HIV protease can be stopped during the maturation process, it will prevent viral particles, or virions, from reaching maturity and, therefore, from becoming infectious.
This work was performed using GPUGRID.net, a voluntary distributed computing platform that harnesses the processing power of thousands of NVIDIA GPU accelerators from household computers made available by the public for research purposes. It’s akin to accessing a virtual supercomputer. One of the benefits of GPU acceleration is that it provides computing power that is around 10 times higher than that generated by computers based on CPUs alone. It reduces research costs accordingly by providing a level computational power that previously was only available on dedicated, multi-million dollar supercomputers.
Researchers use this computing power to process large numbers of data and generate highly complex molecular simulations. In this specific case, thousands of computer simulations have been carried out, each for hundreds of nanoseconds (billionths of a second) for a total of almost a millisecond.
According to researchers, this discovery in the HIV maturation process provides an alternative approach in the design of future pharmaceutical products based on the use of these new molecular mechanisms. For now, this work provides a greater understanding of a crucial step in the life cycle of HIV, a virus that directly attacks and weakens the human immune system, making it vulnerable to a wide range of infections, and which affects millions of people around the world.
Reference:
“Kinetic characterization of the critical step in HIV-1 protease maturation”. S Kashif Sadiq, Frank Noe and Gianni De Fabritiis. PNAS. DOI:10.1073/pnas.1210983109. http://www.pnas.org/content/early/2012/11/21/1210983109.abstract?sid=9e8d7340-4d4c-4fa5-85a2-c68194eff067
Follow GPUGRID.net at: http://facebook.com/gpugrid
Document d'origen: Crucial step in AIDS virus maturation simulated (Nota de premsa)
Número total d'impactes: 102
Número d'impactes classificat per tipus de mitjà:
A continuació us detallem els diferents impactes mediàtics:
03/12/2012 - Bio-medicine
04/12/2012 - Atlántico online
04/12/2012 - Benchmark Review
04/12/2012 - Biocrafts
04/12/2012 - Bitlovers
04/12/2012 - Catalunya Press
04/12/2012 - Cell DNA
04/12/2012 - Connoticias
04/12/2012 - El Economista
04/12/2012 - EE Times
04/12/2012 - El semanal digital
04/12/2012 - En Salud
04/12/2012 - eScience news
04/12/2012 - EurekAlert
04/12/2012 - Europa Press
04/12/2012 - Feed My Science
04/12/2012 - Gaiety thorny
04/12/2012 - Gene Ref
04/12/2012 - Gnom
04/12/2012 - Google news
04/12/2012 - Te interesa
04/12/2012 - GPU Science
04/12/2012 - Gran Canaria Actualidad
04/12/2012 - Gran Canaria Actualidad
04/12/2012 - Grupo Empresarial GET
04/12/2012 - HIV ATLAS
04/12/2012 - I4U
04/12/2012 - Iberoamérica
04/12/2012 - Infection Control Today
04/12/2012 - Interesting Tech
04/12/2012 - Jano
04/12/2012 - La información
04/12/2012 - La Región Internacional
04/12/2012 - La Región digital
04/12/2012 - La Vanguardia digital
04/12/2012 - Lukor
04/12/2012 - La Voz Libre
04/12/2012 - Machines Like Us
04/12/2012 - Medical Xpress
04/12/2012 - Medicina TV
04/12/2012 - NanoWerk
04/12/2012 - National Institute for Health Research
04/12/2012 - News Medical
04/12/2012 - Niuzer
04/12/2012 - Noticias Científicas
04/12/2012 - Nvidia blog
04/12/2012 - PC World
04/12/2012 - Plataforma SINC
04/12/2012 - PYSnoticias
04/12/2012 - Que digital
04/12/2012 - RDI Press
04/12/2012 - Regator
04/12/2012 - Salud y Medicina
04/12/2012 - Scibite
04/12/2012 - Science Codex
04/12/2012 - Science Daily
04/12/2012 - Science Newsline Biology
04/12/2012 - Science Springs
04/12/2012 - Scoop it
04/12/2012 - Terra
04/12/2012 - The Edge
04/12/2012 - Topix
04/12/2012 - Una Página de Noticias
04/12/2012 - Universo Doppler
04/12/2012 - UPF
04/12/2012 - Vilaweb
04/12/2012 - Yahoo noticias
04/12/2012 - Your Shopping Resource
04/12/2012 - CERCA
04/12/2012 - Ebiotrade China
04/12/2012 - El Dia de Córdoba
04/12/2012 - El Mundo digital
04/12/2012 - Fraz PC
04/12/2012 - Krisana
04/12/2012 - Nova Salud
04/12/2012 - Periódico 24
04/12/2012 - Techplayboy
04/12/2012 - Overclockers
05/12/2012 - Chemistry news
05/12/2012 - Diario Médico
05/12/2012 - Globedia
05/12/2012 - Bioportfolio
05/12/2012 - HIV HAVEN
05/12/2012 - India Locals
05/12/2012 - Paperblog
06/12/2012 - Ediciones médicas
06/12/2012 - Guía Bioquímica
06/12/2012 - Medical News Today
06/12/2012 - Prescripción enfermera
06/12/2012 - Supercomputing online
07/12/2012 - Cáscara amarga
08/12/2012 - Diario de Cádiz
08/12/2012 - Diario de Sevilla
08/12/2012 - Huelva Información
08/12/2012 - Málaga Hoy
08/12/2012 - Granada Hoy
08/12/2012 - Diario de Almería
08/12/2012 - Europa Sur
08/12/2012 - Diario de Jerez
09/12/2012 - Medindia
10/12/2012 - ileon
12/12/2012 - Big Country AIDS Resources
Head of Communications:
Rosa Manaut
Communications office:
Marta Calsina(ELIMINAR)
Tel:
(+34) 93 316 06 80
(+34) 699 094 833
Doctor Aiguader, 88
08003 Barcelona
© Institut Hospital del Mar d'Investigacions Mèdiques Legal Note | Cookie Policy | Site Index | Accessibility | Find Us | Contact